RSLS: Reshape Lifesciences Inc Financial Statements
Balance sheet, income statement, and cash flow statements for Reshape Lifesciences Inc (RSLS).
$3.18M Market Cap.
RSLS Market Cap. (MRY)
RSLS Shares Outstanding (MRY)
RSLS Assets (MRY)
Total Assets
$4.79M
Total Liabilities
$5.05M
Total Investments
$0
RSLS Income (MRY)
Revenue
$8.01M
Net Income
-$7.13M
Operating Expense
$12.79M
RSLS Cash Flow (MRY)
CF Operations
-$4.43M
CF Investing
$0
CF Financing
$677.00K
RSLS Balance Sheet (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total Assets | $4,793,000 (-55.05%) | $10,663,000 (-4.30%) | $11,142,000 (-78.79%) | $52,531,000 (41.74%) |
Assets Current | $4,588,000 (-55.44%) | $10,296,000 (3.88%) | $9,911,000 (-66.89%) | $29,938,000 (234.73%) |
Assets Non-Current | $205,000 (-44.14%) | $367,000 (-70.19%) | $1,231,000 (-94.55%) | $22,593,000 (-19.65%) |
Goodwill & Intangible Assets | $0 (0%) | $0 (0%) | $260,000 (-98.75%) | $20,827,000 (-22.93%) |
Shareholders Equity | -$253,000 (-103.80%) | $6,663,000 (82.00%) | $3,661,000 (-91.74%) | $44,334,000 (206.00%) |
Property Plant & Equipment Net | $154,000 (-50.32%) | $310,000 (-64.33%) | $869,000 (-49.48%) | $1,720,000 (63.97%) |
Cash & Equivalents | $793,000 (-82.61%) | $4,559,000 (15.27%) | $3,955,000 (-82.66%) | $22,815,000 (658.73%) |
Accumulated Other Comprehensive Income | -$104,000 (-18.18%) | -$88,000 (0.00%) | -$88,000 (4.35%) | -$92,000 (23.97%) |
Deferred Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Investments | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Investments Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Investments Non-Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Inventory | $2,460,000 (-34.24%) | $3,741,000 (3.60%) | $3,611,000 (20.25%) | $3,003,000 (33.82%) |
Trade & Non-Trade Receivables | $987,000 (-40.51%) | $1,659,000 (-23.90%) | $2,180,000 (-22.56%) | $2,815,000 (7.44%) |
Trade & Non-Trade Payables | $2,208,000 (30.73%) | $1,689,000 (-12.31%) | $1,926,000 (-44.46%) | $3,468,000 (-5.12%) |
Accumulated Retained Earnings (Deficit) | -$642,704,000 (-1.12%) | -$635,574,000 (-1.82%) | -$624,187,000 (-8.00%) | -$577,973,000 (-12.27%) |
Tax Assets | $22,000 (-21.43%) | $28,000 (-50.00%) | $56,000 (0%) | $0 (0%) |
Tax Liabilities | $0 (0%) | $0 (0%) | $0 (0%) | $367,000 (-40.33%) |
Total Debt | $967,000 (269.08%) | $262,000 (53.22%) | $171,000 (-38.71%) | $279,000 (-97.89%) |
Debt Current | $926,000 (734.23%) | $111,000 (-35.09%) | $171,000 (-38.71%) | $279,000 (-92.89%) |
Debt Non-Current | $41,000 (-72.85%) | $151,000 (0%) | $0 (0%) | $0 (0%) |
Total Liabilities | $5,046,000 (26.15%) | $4,000,000 (-46.53%) | $7,481,000 (-8.73%) | $8,197,000 (-63.69%) |
Liabilities Current | $4,985,000 (31.98%) | $3,777,000 (-49.51%) | $7,481,000 (-0.65%) | $7,530,000 (-35.11%) |
Liabilities Non-Current | $61,000 (-72.65%) | $223,000 (0%) | $0 (0%) | $667,000 (-93.92%) |
RSLS Income Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Revenues | $8,006,000 (-7.74%) | $8,678,000 (-22.79%) | $11,240,000 (-17.35%) | $13,600,000 (20.36%) |
Cost of Revenue | $2,949,000 (-5.78%) | $3,130,000 (-29.47%) | $4,438,000 (-15.50%) | $5,252,000 (4.27%) |
Selling General & Administrative Expense | $9,922,000 (-44.48%) | $17,872,000 (-42.98%) | $31,343,000 (-5.63%) | $33,212,000 (118.20%) |
Research & Development Expense | $1,803,000 (-22.12%) | $2,315,000 (-8.75%) | $2,537,000 (7.09%) | $2,369,000 (-32.28%) |
Operating Expenses | $12,785,000 (-38.92%) | $20,931,000 (-60.62%) | $53,153,000 (-19.74%) | $66,230,000 (253.81%) |
Interest Expense | $0 (0%) | $0 (0%) | $113,000 (-86.42%) | $832,000 (-59.39%) |
Income Tax Expense | $39,000 (-25.00%) | $52,000 (113.68%) | -$380,000 (-38.69%) | -$274,000 (-51.38%) |
Net Loss Income from Discontinued Operations | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Consolidated Income | -$7,130,000 (37.38%) | -$11,387,000 (75.36%) | -$46,214,000 (26.81%) | -$63,146,000 (-191.94%) |
Net Income to Non-Controlling Interests | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income | -$7,130,000 (37.38%) | -$11,387,000 (75.36%) | -$46,214,000 (26.81%) | -$63,146,000 (-191.94%) |
Preferred Dividends Income Statement Impact | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income Common Stock | -$7,130,000 (37.38%) | -$11,387,000 (75.36%) | -$46,214,000 (26.81%) | -$63,146,000 (-191.94%) |
Weighted Average Shares | $20,623 (402.02%) | $4,108 (1302.05%) | $293 (94.04%) | $151 (179.63%) |
Weighted Average Shares Diluted | $20,623 (402.02%) | $4,108 (1302.05%) | $293 (94.04%) | $151 (179.63%) |
Earning Before Interest & Taxes (EBIT) | -$7,091,000 (37.44%) | -$11,335,000 (75.61%) | -$46,481,000 (25.73%) | -$62,588,000 (-216.71%) |
Gross Profit | $5,057,000 (-8.85%) | $5,548,000 (-18.44%) | $6,802,000 (-18.52%) | $8,348,000 (33.31%) |
Operating Income | -$7,728,000 (49.76%) | -$15,383,000 (66.81%) | -$46,351,000 (19.92%) | -$57,882,000 (-364.65%) |
RSLS Cash Flow Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Net Cash Flow from Investing | $0 (0%) | -$10,000 (89.13%) | -$92,000 (-104.96%) | $1,855,000 (177.62%) |
Net Cash Flow from Financing | $677,000 (-96.15%) | $17,574,000 (461.47%) | $3,130,000 (-90.60%) | $33,299,000 (200.67%) |
Net Cash Flow from Operations | -$4,427,000 (73.90%) | -$16,960,000 (22.56%) | -$21,902,000 (-42.45%) | -$15,375,000 (-79.82%) |
Net Cash Flow / Change in Cash & Cash Equivalents | -$3,766,000 (-723.51%) | $604,000 (103.20%) | -$18,860,000 (-195.21%) | $19,808,000 (89936.36%) |
Net Cash Flow - Business Acquisitions and Disposals | $0 (0%) | $0 (0%) | $0 (0%) | $2,207,000 (210.35%) |
Net Cash Flow - Investment Acquisitions and Disposals | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Capital Expenditure | $0 (0%) | -$10,000 (89.13%) | -$92,000 (73.86%) | -$352,000 (9.74%) |
Issuance (Repayment) of Debt Securities | $653,000 (0%) | $0 (0%) | $0 (0%) | -$12,734,000 (-222.49%) |
Issuance (Purchase) of Equity Shares | $24,000 (-99.86%) | $17,574,000 (461.47%) | $3,130,000 (-93.20%) | $46,033,000 (6679.53%) |
Payment of Dividends & Other Cash Distributions | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Effect of Exchange Rate Changes on Cash | -$16,000 (0%) | $0 (0%) | $4,000 (-86.21%) | $29,000 (125.66%) |
Share Based Compensation | $184,000 (-75.98%) | $766,000 (-63.30%) | $2,087,000 (-82.93%) | $12,227,000 (824.19%) |
Depreciation Amortization & Accretion | $22,000 (-85.71%) | $154,000 (-92.85%) | $2,153,000 (9.23%) | $1,971,000 (18.24%) |
RSLS Financial Metrics (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Gross Margin | 63.20% (-1.10%) | 63.90% (5.62%) | 60.50% (-1.47%) | 61.40% (10.83%) |
Profit Margin | -89.10% (32.09%) | -131.20% (68.09%) | -411.20% (11.44%) | -464.30% (-142.58%) |
EBITDA Margin | -88.30% (31.44%) | -128.80% (67.34%) | -394.40% (11.51%) | -445.70% (-178.39%) |
Return on Average Equity (ROAE) | -324.00% (-72.43%) | -187.90% (2.84%) | -193.40% (-46.85%) | -131.70% (41.15%) |
Return on Average Assets (ROAA) | -113.90% (-16.82%) | -97.50% (32.06%) | -143.50% (-59.44%) | -90.00% (14.61%) |
Return on Sales (ROS) | -88.60% (32.16%) | -130.60% (68.42%) | -413.50% (10.15%) | -460.20% (-163.12%) |
Return on Invested Capital (ROIC) | -502.30% (22.04%) | -644.30% (74.06%) | -2484.00% (-280.54%) | 1375.90% (440.74%) |
Dividend Yield | 0% (0%) | 0% (0%) | 0% (0%) | 0% (0%) |
Price to Earnings Ratio (P/E) | -0.32 (-145.80%) | -0.13 (-111.29%) | -0.06 (78.17%) | -0.28 (65.02%) |
Price to Sales Ratio (P/S) | 0.29 (67.84%) | 0.17 (-32.68%) | 0.25 (-80.73%) | 1.32 (-15.24%) |
Price to Book Ratio (P/B) | -12.56 (-2653.46%) | 0.49 (-44.72%) | 0.89 (35.26%) | 0.66 (-18.26%) |
Debt to Equity Ratio (D/E) | -19.95 (-3424.17%) | 0.6 (-70.63%) | 2.04 (1004.32%) | 0.18 (-88.13%) |
Earnings Per Share (EPS) | -345.75 (87.53%) | -2,771.75 (98.24%) | -157,905 (62.31%) | -419,006.5 (-4.32%) |
Sales Per Share (SPS) | 388.21 (-81.62%) | 2,112.32 (-94.50%) | 38,403.32 (-57.44%) | 90,242.53 (-56.98%) |
Free Cash Flow Per Share (FCFPS) | -214.67 (94.80%) | -4,130.68 (94.50%) | -75,146.15 (27.99%) | -104,356.19 (37.13%) |
Book Value Per Share (BVPS) | -12.27 (-100.76%) | 1,621.85 (-87.03%) | 12,508.41 (-95.75%) | 294,177.37 (9.36%) |
Tangible Assets Book Value Per Share (TABVPS) | 232.41 (-91.05%) | 2,595.49 (-93.02%) | 37,180.16 (-82.33%) | 210,371.26 (12.86%) |
Enterprise Value Over EBIT (EV/EBIT) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
Enterprise Value Over EBITDA (EV/EBITDA) | -0.36 (-98.33%) | -0.18 (-390.32%) | 0.06 (212.73%) | -0.06 (87.09%) |
Asset Turnover | 1.28 (72.14%) | 0.74 (112.89%) | 0.35 (79.90%) | 0.19 (-64.73%) |
Current Ratio | 0.92 (-66.25%) | 2.73 (105.74%) | 1.32 (-66.68%) | 3.98 (415.69%) |
Dividends | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Free Cash Flow (FCF) | -$4,427,000 (73.91%) | -$16,970,000 (22.84%) | -$21,994,000 (-39.85%) | -$15,727,000 (-75.92%) |
Enterprise Value (EV) | $2,526,553 (25.33%) | $2,015,929 (173.79%) | -$2,732,017 (-182.37%) | $3,316,813 (-56.97%) |
Earnings Before Tax (EBT) | -$7,091,000 (37.44%) | -$11,335,000 (75.67%) | -$46,594,000 (26.53%) | -$63,420,000 (-190.77%) |
Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | -$7,069,000 (36.78%) | -$11,181,000 (74.78%) | -$44,328,000 (26.87%) | -$60,617,000 (-234.99%) |
Invested Capital | -$18,000 (-100.70%) | $2,589,000 (775.98%) | -$383,000 (-123.38%) | $1,638,000 (-81.13%) |
Working Capital | -$397,000 (-106.09%) | $6,519,000 (168.27%) | $2,430,000 (-89.16%) | $22,408,000 (942.09%) |
Tangible Asset Value | $4,793,000 (-55.05%) | $10,663,000 (-2.01%) | $10,882,000 (-65.68%) | $31,704,000 (215.81%) |
Market Capitalization | $3,178,553 (-3.09%) | $3,279,929 (0.64%) | $3,258,983 (-88.83%) | $29,165,813 (150.22%) |
Average Equity | $2,200,750 (-63.69%) | $6,060,500 (-74.64%) | $23,898,000 (-50.15%) | $47,942,750 (396.05%) |
Average Assets | $6,258,000 (-46.39%) | $11,673,500 (-63.74%) | $32,198,250 (-54.10%) | $70,143,000 (241.64%) |
Invested Capital Average | $1,411,750 (-19.75%) | $1,759,250 (-5.99%) | $1,871,250 (141.14%) | -$4,548,750 (-192.95%) |
Shares | 28,507 (214.68%) | 9,059 (2620.42%) | 333 (35.92%) | 245 (580.56%) |
